急诊科罗库溴铵快速序贯插管后的镇痛镇静干预
该回顾性队列研究在美国一家学术急诊科开展,纳入2015年1月至2016年6月连续接受依托咪酯联合罗库溴铵快速序贯插管的成年患者108例,旨在比较插管后早期(0-30分钟)与晚期(60-90分钟)镇痛镇静干预次数,并描述首次干预时间。结果显示早期干预中位数2次(IQR 1-3),晚期0次(IQR 0-1),差异有统计学意义(p<0.001);首次镇痛镇静干预中位时间为7分钟(IQR 3-13分钟)。作者结论认为,在药学主导教育项目后,急诊使用罗库溴铵快速序贯插管并未延迟插管后镇痛镇静的提供。
要点
- 早期(0-30分钟)镇痛镇静干预中位数2次(IQR 1-3),晚期(60-90分钟)0次(IQR 0-1),p<0.001。
- 首次镇痛镇静干预中位时间为7分钟(IQR 3-13分钟),未见延迟。
- 研究人群为连续接受依托咪酯联合罗库溴铵快速序贯插管的成年患者,平均罗库溴铵剂量1.1±0.3 mg/kg。
- 该结果来自药学主导教育项目后的单中心回顾性队列,作者结论为未延迟插管后镇痛镇静。
适用人群与场景
- 美国一家学术急诊科连续纳入的成年患者,接受依托咪酯联合罗库溴铵快速序贯插管。
- 研究于2015年1月至2016年6月开展,在药学主导教育项目之后进行。
研究设计与关键结果
- 研究类型为回顾性队列研究,样本量108例,平均年龄58±19岁,男性62例(57%)。
- 平均罗库溴铵剂量为1.1±0.3 mg/kg。
- 主要终点:插管后早期(0-30分钟)镇痛镇静干预中位数2次(IQR 1-3)vs 晚期(60-90分钟)0次(IQR 0-1),p<0.001。
- 次要终点:首次镇痛镇静干预中位时间7分钟(IQR 3-13分钟)。
- 镇痛镇静干预定义为启动阿片类药物或镇静药,或增加输注速率。
证据类型、等级与局限
- 证据类型:回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者结论认为,在药学主导教育项目后,急诊使用罗库溴铵快速序贯插管并未延迟插管后镇痛镇静的提供。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: The use of etomidate and rocuronium for rapid sequence intubation (RSI) results in a duration of paralysis that exceeds the duration of sedation. The primary objective of this study was to compare the number of analgosedative (AGS) interventions early versus late post-RSI, with this drug combination. The secondary objective was to descriptively assess time to first AGS intervention.
METHODS: This was a retrospective cohort study conducted in an academic ED in the United States between January 2015 and June 2016. The study was conducted after a pharmacy-led education program. Consecutive adult patients who received the combination of etomidate and rocuronium for RSI were included. The primary outcome measure was the number of AGS interventions post-RSI. An AGS intervention was defined as initiation of an opioid or sedative, or a dose increase of an infusion rate. Interventions were categorized as early (0-30min post-RSI) or late (60-90min post-RSI).
RESULTS: The sample (n=108) had a mean age of 58±19years, and the majority was male (n=62, 57%). The mean rocuronium dose was 1.1±0.3mg/kg. There was a median of 2 interventions (IQR 1-3) that occurred early versus 0 interventions (IQR 0 to 1) that occurred late post-RSI (p<0.001). The median time to first AGS intervention was 7min (IQR 3 to 13min).
CONCLUSIONS: When rocuronium was used for RSI in the ED there was no delay in provision of post-intubation sedation or analgesia, after a pharmacy-led educational program.
参考来源
- Kilber E, Jarrell DH, Sakles JC, et al. Analgosedative interventions after rapid sequence intubation with rocuronium in the emergency department. Am J Emerg Med. 2017. PMID: 29157794. doi:10.1016/j.ajem.2017.11.022
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。